These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34930220)

  • 1. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.
    Wang JR; Mendez Araque SJ; Micciche G; McMillan A; Coughlin E; Mattiola R; English D; Kaliebe K
    Front Psychiatry; 2024; 15():1301960. PubMed ID: 38699449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.
    Mayer CE; LeBaron VT; Acquaviva KD
    J Psychoactive Drugs; 2022; 54(1):81-92. PubMed ID: 34266372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care.
    Nigam K; Curseen KA; Beaussant Y
    Clin Geriatr Med; 2023 Aug; 39(3):423-436. PubMed ID: 37385694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.
    Rosa WE; Sager Z; Miller M; Bernstein I; Doerner Rinaldi A; Addicott K; Ljuslin M; Adrian C; Back AL; Beachy J; Bossis AP; Breitbart WS; Cosimano MP; Fischer SM; Guss J; Knighton E; Phelps J; Richards BD; Richards WA; Tulsky JA; Williams MT; Beaussant Y
    J Palliat Med; 2022 Aug; 25(8):1273-1281. PubMed ID: 35285721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.
    Beaussant Y; Tulsky J; Guérin B; Schwarz-Plaschg C; Sanders JJ;
    J Palliat Med; 2021 Nov; 24(11):1657-1666. PubMed ID: 33848208
    [No Abstract]   [Full Text] [Related]  

  • 8. Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.
    Plourde L; Chang SL; Farzin H; Gagnon P; Hébert J; Foxman R; Deschamps P; Provost F; Masse-Grenier M; Stephan JF; Cheung K; Joly Y; Fallu JS; Dorval M;
    Palliat Med; 2024 Feb; 38(2):272-278. PubMed ID: 38253521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.
    Miller M; Rosa WE; Doerner Rinaldi A; Addicott K; Spence D; Beaussant Y
    Psychedelic Med (New Rochelle); 2023 Sep; 1(3):124-129. PubMed ID: 37753521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption as an opportunity or threat: A qualitative analysis of factors influencing the attitudes of experts in serious illness care toward psychedelic-assisted therapies.
    Sholevar R; Peteet J; Sanders J; Beaussant Y
    Palliat Support Care; 2023 Oct; ():1-6. PubMed ID: 37818641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.
    Meir P; Taylor L; Soares JC; Meyer TD
    J Affect Disord; 2023 Feb; 323():748-754. PubMed ID: 36535547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
    Schimmers N; Breeksema JJ; Smith-Apeldoorn SY; Veraart J; van den Brink W; Schoevers RA
    Psychopharmacology (Berl); 2022 Jan; 239(1):15-33. PubMed ID: 34812901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do Australian palliative care nurses address existential and spiritual concerns? Facilitators, barriers and strategies.
    Keall R; Clayton JM; Butow P
    J Clin Nurs; 2014 Nov; 23(21-22):3197-205. PubMed ID: 25453124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.
    Peacock C; Mascaro JS; Brauer E; Zarrabi AJ; Dunlop BW; Maples-Keller JL; Grant GH; Raison CL; Rab F; Palitsky R
    PLoS One; 2024; 19(1):e0296071. PubMed ID: 38166057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How specialist palliative care nurses identify patients with existential distress and manage their needs.
    Fay Z; OBoyle C
    Int J Palliat Nurs; 2019 May; 25(5):233-243. PubMed ID: 31116658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives.
    Beaussant Y; Sanders J; Sager Z; Tulsky JA; Braun IM; Blinderman CD; Bossis AP; Byock I
    J Palliat Med; 2020 Oct; 23(10):1323-1334. PubMed ID: 32233936
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory psycho-existential distress and continuous deep sedation until death in palliative care: The French perspective.
    Reich M; Bondenet X; Rambaud L; Ait-Kaci F; Sedda AL; Da Silva A; Villet S; Gamblin V
    Palliat Support Care; 2020 Aug; 18(4):486-494. PubMed ID: 31551106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential of Psychedelics for End of Life and Palliative Care.
    Yaden DB; Nayak SM; Gukasyan N; Anderson BT; Griffiths RR
    Curr Top Behav Neurosci; 2022; 56():169-184. PubMed ID: 34958455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Palliative Sedation for Existential Distress? A Survey of Canadian Palliative Care Physicians' Views.
    Voeuk A; Nekolaichuk C; Fainsinger R; Huot A
    J Palliat Care; 2017 Jan; 32(1):26-33. PubMed ID: 28662627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.